It is a pharma private limited company based in Amberpet, Telangana, India, established in 2020.
2020 | Amberpet, Telangana, India | ActiveRasimo Lifesciences Private Limited, a active private limited company, was established on 17 October 2020 in Amberpet, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909TG2020PTC144973. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.30 M.
It upholds a compliant status. Its leadership includes Kamrudin Kurbanali Meghani (Director), Sadiq Shoukatali Surani (Director), Sikander Manjyani (Director). Past directors included Kamrudin Kurbanali Meghani, Sadiq Shoukatali Surani, Rahim Mohammed Samnani. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 16-11-511/D/404, Ground And First Floor, Moosarambagh, Amberpet, Telangana, 500036.
U51909TG2020PTC144973
144973
17 October 2020
₹1.00 M
₹0.30 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Rasimo Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamrudin Kurbanali Meghani | Director | 14 Oct 2023 | Current |
| Sadiq Shoukatali Surani | Director | 14 Oct 2023 | Current |
| Sikander Manjyani | Director | 17 Oct 2020 | Current |
| Moin Panjwani | Director | 17 Oct 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 17 Jan 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rasimo Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1640.95% increase. The company also saw a substantial fall in profitability, with a 10.05% decrease in profit. The company's net worth observed a substantial decline by a decrease of 157.78%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rasimo Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Rasimo Lifesciences has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rasimo Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rasimo Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rasimo Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Rasimo Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Kamrudin Kurbanali Meghani was appointed as a Director was appointed as a Director on 14 Oct 2023 & has been associated with this company since 2 years 2 months . was recorded as a recent event.
The activity Sadiq Shoukatali Surani was appointed as a Director was appointed as a Director on 14 Oct 2023 & has been associated with this company since 2 years 2 months . was completed.
Sikander Manjyani was appointed as a Director was appointed as a Director on 17 Oct 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
Moin Panjwani was appointed as a Director was appointed as a Director on 17 Oct 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
The CIN of Rasimo Lifesciences Private Limited is U51909TG2020PTC144973.
Rasimo Lifesciences Private Limited is headquartered at 16-11-511/D/404, Ground And First Floor, Moosarambagh, Amberpet, Telangana, 500036.
Rasimo Lifesciences Private Limited was incorporated on 17 October 2020.
The current directors of Rasimo Lifesciences Private Limited are
The primary industry of Rasimo Lifesciences Private Limited is Trade.
Rasimo Lifesciences Private Limited is unlisted.
The authorized capital of Rasimo Lifesciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.30 M.
The compliance status of Rasimo Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX